Bioequivalence and generic prescribing: A pharmacy view

被引:7
作者
Calvert, RT
机构
关键词
D O I
10.1111/j.2042-7158.1996.tb05867.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:9 / 10
页数:2
相关论文
共 9 条
[1]   BIOINEQUIVALENCE AND DRUG TOXICITY - HOW GREAT IS THE PROBLEM AND WHAT CAN BE DONE [J].
GLEITER, CH ;
GUNDERTREMY, U .
DRUG SAFETY, 1994, 11 (01) :1-6
[2]   DRUG-THERAPY - BIOAVAILABILITY OF DRUGS .1. [J].
KOCHWESE.J .
NEW ENGLAND JOURNAL OF MEDICINE, 1974, 291 (05) :233-237
[3]   VARIATION IN BIOLOGIC AVAILABILITY OF DIGOXIN FROM 4 PREPARATIONS [J].
LINDENBAUM, J ;
MELLOW, MH ;
BLACKSTONE, MO ;
BUTLER, VP .
NEW ENGLAND JOURNAL OF MEDICINE, 1971, 285 (24) :1344-+
[4]   GENERIC DRUGS AND THE PRESCRIBING PHYSICIAN [J].
NIGHTINGALE, SL ;
MORRISON, JC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 258 (09) :1200-1204
[5]   GENERIC SUBSTITUTION [J].
SNELL, ES .
BRITISH MEDICAL JOURNAL, 1983, 286 (6372) :1216-1217
[6]  
Tozer, 1989, CLIN PHARMACOKINETIC
[7]  
1994, PRESCRIPTION IMPROVE
[8]  
1995, MERC B, V6, P9
[9]  
1991, RULES GOVERNING MED, V3, P149